Morgan Stanley
DERM icon

Morgan Stanley’s Journey Medical DERM Stock Holding History

Morgan Stanley’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.4K Sell
10,535
-15,965
-60% -$124K ﹤0.01% 6427
2025
Q4 		$204K Buy
26,500
+5,768
+28% +$45.2K ﹤0.01% 5922
2025
Q3 		$148K Sell
20,732
-31,182
-60% -$226K ﹤0.01% 6003
2025
Q2 		$373K Buy
51,914
+37,721
+266% +$261K ﹤0.01% 5597
2025
Q1 		$83.7K Buy
14,193
+4,493
+46% +$22.1K ﹤0.01% 6095
2024
Q4 		$37.9K Buy
+9,700
New +$53K ﹤0.01% 6375
2024
Q2 		– Sell
-550
Closed -$2.02K – 7869
2024
Q1 		$2.02K Buy
550
+150
+38% +$653 ﹤0.01% 7070
2023
Q4 		$2.3K Buy
+400
New +$1.78K ﹤0.01% 7120

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley's DERM Position: Q1 2026 in Review

Morgan Stanley reduced its Journey Medical (DERM) stake by 60% in Q1 2026, selling an estimated $124K and leaving 10,535 shares worth $49.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6427.

Morgan Stanley first reported a position in DERM in Q4 2023 and has held it in 8 quarters since. The position peaked at $373K in Q2 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Morgan Stanley held 10,535 shares of Journey Medical worth $49.4K as of Q1 2026.
  • Morgan Stanley sold 15,965 Journey Medical shares in Q1 2026, an estimated $124K.
  • Journey Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6427 holding.
  • Morgan Stanley first reported a position in Journey Medical in Q4 2023 and has held it in 8 quarters since.
  • Morgan Stanley's Journey Medical position peaked at $373K in Q2 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.